Adam Mayerson, MD, FACE
DownloadHi-Res Photo
Cards
Titles
Associate Clinical Professor of Medicine; Associate Chief of Medicine
About
Titles
Medical Services Provider
Associate Clinical Professor of Medicine; Associate Chief of MedicineAppointments
Endocrinology
Associate Clinical ProfessorPrimary
Other Departments & Organizations
Education & Training
- Fellowship, Endocrinology
- Yale University School of Medicine (2001)
- Residency
- Yale-New Haven Hospital (1999)
- MD
- Albert Einstein College of Medicine (1996)
- BA
- Brandeis University, Biology (1992)
Research
Research at a Glance
Yale Co-Authors
Frequent collaborators of Adam Mayerson's published research.
Publications Timeline
A big-picture view of Adam Mayerson's research output by year.
Diana Athonvarangkul, MD/PhD
8Publications
1,216Citations
Publications
2023
Improved extremity tissue oxygenation with short-term exposure to textiles embedded with far infrared light emitting thermoactive particles in patients with diabetes mellitus
Athonvarangkul D, Wang K, Deng Y, Inzucchi S, Mayerson A. Improved extremity tissue oxygenation with short-term exposure to textiles embedded with far infrared light emitting thermoactive particles in patients with diabetes mellitus. Diabetes And Vascular Disease Research 2023, 20: 14791641231170282. PMID: 37073436, PMCID: PMC10123901, DOI: 10.1177/14791641231170282.Peer-Reviewed Original ResearchCitationsMeSH Keywords and Concepts
2008
Development of Thyroid Storm After Surgical Resection of A Thyrotropin-Secreting Pituitary Adenoma
Page KA, Roehmholdt BF, Jablonski M, Mayerson AB. Development of Thyroid Storm After Surgical Resection of A Thyrotropin-Secreting Pituitary Adenoma. Endocrine Practice 2008, 14: 732-737. PMID: 18996794, DOI: 10.4158/ep.14.6.732.Peer-Reviewed Case Reports and Technical NotesCitationsMeSH Keywords and ConceptsConceptsPostoperative thyroid stormThyroid stormSurgical resectionSuprasellar tumorsPituitary adenomasThyrotropin-secreting pituitary adenomaBeta-adrenergic blocking agentsLarge suprasellar tumorsTSH-secreting adenomaThyroid-stimulating hormoneLaboratory evaluationThyroid hormone levelsPostoperative thyrotoxicosisHormonal abnormalitiesHormonal evaluationPituitary massYounger patientsInitial presentationMale patientsSevere headachePathologic findingsCase reportHormone levelsBlocking agentSurgical procedures
2007
Levemir® Early Clinical Experience Case Series
Mayerson AB. Levemir® Early Clinical Experience Case Series. Endocrinology And Metabolism Clinics Of North America 2007, 36: 45-52. PMID: 17881331, DOI: 10.1016/s0889-8529(07)80007-7.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsMeSH Keywords and ConceptsConceptsInsulin detemirCase seriesDiscontinuation of treatmentMean weight lossLarge observational studiesType 2 diabetesDaily regimenFinal followTreatment discontinuationGlycemic controlTreatment initiationHypoglycemic episodesA1C valuesCase reportThird followObservational studyDetemirMean decreasePatientsSpecial interventionDoctor's officeWeight lossObservation periodDiscontinuationRegimenA Woman With Chronic Urticaria and Graves Disease
Goldberg P, Mayerson A. A Woman With Chronic Urticaria and Graves Disease. The Endocrinologist 2007, 17: 217-220. DOI: 10.1097/ten.0b013e3181237999.Peer-Reviewed Case Reports and Technical NotesCitationsConceptsChronic urticariaGraves' diseaseElevated thyroid peroxidase antibodiesNormal thyroid function testsNew-onset hyperthyroidismNear-total thyroidectomyThyroid peroxidase antibodiesDay of surgeryThyroid-stimulating immunoglobulinThyroid function testsAutoimmune thyroid diseaseMU/LSeverity of urticariaElevated thyroxine levelsInitial laboratory evaluationNuclear imaging studiesDiffuse myalgiaStandard therapyThyroid autoimmunityClinical courseMedical therapyPeroxidase antibodiesTherapeutic trialsThyrotropin levelsFunction tests
2005
Tumor‐to‐tumor metastasis to a thyroid follicular adenoma as the initial presentation of a colonic adenocarcinoma
Fadare O, Parkash V, Fiedler PN, Mayerson AB, Asiyanbola B. Tumor‐to‐tumor metastasis to a thyroid follicular adenoma as the initial presentation of a colonic adenocarcinoma. Pathology International 2005, 55: 574-579. PMID: 16143033, DOI: 10.1111/j.1440-1827.2005.01871.x.Peer-Reviewed Case Reports and Technical NotesCitationsMeSH Keywords and ConceptsConceptsThyroid neoplasmsMetastatic depositsDonor tumorTumor metastasisColonic adenocarcinoma metastaticSigmoid colon tumorInitial clinical manifestationPossibility of metastasisLower gastrointestinal tractThyroid follicular adenomaAutopsy seriesMetastatic diseaseSurgical seriesInitial presentationRecipient tumorClinical manifestationsHistopathologic characteristicsThyroid involvementAdenocarcinoma metastaticImmunohistochemical profileColonic adenocarcinomaDifferential diagnosisNecropsy findingsGastrointestinal tractThyroid tumors
2002
Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes
Hundal RS, Petersen KF, Mayerson AB, Randhawa PS, Inzucchi S, Shoelson SE, Shulman GI. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. Journal Of Clinical Investigation 2002, 109: 1321-1326. PMID: 12021247, PMCID: PMC150979, DOI: 10.1172/jci14955.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsAspirin treatmentInsulin resistanceTolerance testPlasma glucoseInsulin-stimulated peripheral glucose uptakeHigh-dose aspirin treatmentMixed meal tolerance testType 2 diabetic subjectsMixed-meal tolerance testType 2 diabetes mellitusHigh-dose aspirinWeeks of treatmentC-reactive proteinPeripheral glucose uptakeHyperinsulinemic-euglycemic clampType 2 diabetesPlasma insulin concentrationHepatic glucose productionFatty acid levelsDiabetes mellitusDiabetic subjectsTotal cholesterolGlucose toleranceInsulin clearanceTissue inflammationType 2 diabetes therapy
Mayerson AB, Inzucchi SE. Type 2 diabetes therapy. Postgraduate Medicine 2002, 111: 83-95. PMID: 11912999, DOI: 10.3810/pgm.2002.03.1140.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitationsMeSH Keywords and ConceptsThe Effects of Rosiglitazone on Insulin Sensitivity, Lipolysis, and Hepatic and Skeletal Muscle Triglyceride Content in Patients With Type 2 Diabetes
Mayerson AB, Hundal RS, Dufour S, Lebon V, Befroy D, Cline GW, Enocksson S, Inzucchi SE, Shulman GI, Petersen KF. The Effects of Rosiglitazone on Insulin Sensitivity, Lipolysis, and Hepatic and Skeletal Muscle Triglyceride Content in Patients With Type 2 Diabetes. Diabetes 2002, 51: 797-802. PMID: 11872682, PMCID: PMC2995527, DOI: 10.2337/diabetes.51.3.797.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsMeSH KeywordsAdipocytesAdipose TissueBlood GlucoseBody CompositionCalorimetry, IndirectDiabetes Mellitus, Type 2Fatty AcidsGlucose Clamp TechniqueGlycated HemoglobinGlycerolHumansHyperinsulinismInsulinKineticsLipidsLipolysisLiverMagnetic Resonance SpectroscopyMicrodialysisMiddle AgedMuscle, SkeletalOxidation-ReductionRosiglitazoneThiazolesThiazolidinedionesTriglyceridesConceptsPlasma fatty acid concentrationsMuscle triglyceride contentEffects of rosiglitazoneType 2 diabetesInsulin sensitivityPeripheral adipocytesTriglyceride contentRosiglitazone treatmentFatty acid concentrationsTwo-step hyperinsulinemic-euglycemic clampSkeletal muscle triglyceride contentType 2 diabetic subjectsInsulin-stimulated glucose metabolismWhole-body insulin sensitivityExtramyocellular lipid contentInsulin-responsive organHepatic triglyceride contentHyperinsulinemic-euglycemic clampAdipocyte insulin sensitivityDiabetic subjectsInsulin clampGlucose metabolismGlycerol releaseResponsive organSubcutaneous fat
Academic Achievements and Community Involvement
honor Top Docs 2022
Regional AwardConnecticut MagazineDetails10/13/2022United Stateshonor Top Docs 2021
Regional AwardConnecticut MagazineDetails10/13/2022United Stateshonor Connecticut Magazine Top Docs 2016
Regional AwardConnecticut MagazineDetails04/01/2016United Stateshonor Connecticut Magazine Top Docs 2015
Regional AwardConnecticut MagazineDetails04/03/2015United States
Clinical Care
Overview
Clinical Specialties
Internal Medicine; Endocrinology
Board Certifications
Endocrinology Diabetes & Metabolism
- Certification Organization
- AB of Internal Medicine
- Latest Certification Date
- 2023
- Original Certification Date
- 2001
Internal Medicine
- Certification Organization
- AB of Internal Medicine
- Latest Certification Date
- 2023
- Original Certification Date
- 2000
Yale Medicine News
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileLinks & Media
News
- February 14, 2024
Yale Faculty Honored at Inaugural Voluntary Faculty Awards
- October 03, 2022
Voluntary Faculty Contributions to Department of Internal Medicine
- June 14, 2019
Over 200 Yale Medicine Physicians Make 2019 ‘Best Doctors’ List
- May 03, 2017
Yale Medicine Physicians On 'Top Docs’ List
Get In Touch
Contacts
Secondary Academic Office Number
Appointment Number